The care of people with brain tumors requires the use of highly specialized brain monitoring and neuroimaging equipment to guide therapies that rid the brain of diseased tissue without damaging healthy tissues.
Dr. Andrew Sloan is an expert on brain imaging, having spent his career studying and teaching computer navigation. Image-guided systems are used to treat complicated tumors or those that are hard to access. Dr. Sloan also is a leader in treating brain tumors and helping develop new technologies.
The state-of-the-art technology available at the Brain Tumor and Neuro-Oncology Center includes:
- AutoLITT: AutoLITT (laser interstitial thermal therapy) technology uses MRI-guided lasers to destroy tumors without damaging the surrounding healthy tissue. This revolutionary and minimally invasive approach is especially effective in treating glioblastoma, one of the most aggressive and difficult-to-treat brain cancers.
- CyberKnife®: CyberKnife is a painless, non-invasive technology giving patients new hope for treatment of tumors and lesions previously diagnosed as untreatable or inoperable.
- Gamma Knife: Gamma Knife radiosurgery delivers critical radiation to precisely targeted area in a single fraction, sparing the surrounding tissues. The noninvasive procedure delivers 201 narrow beams of cobalt gamma radiation that are precisely focused on a single target. The tissue being treated receives the highest dose of radiation, while surrounding tissue is left minimally affected.
- Intraoperative MR Operating Suites: The Brain Tumor and Neuro-Oncology Center has one of the world’s first intraoperative MR operating suites and the first in Ohio: Intraoperative MR scans are used to track surgical progress in real time. The intraoperative MR operative suite is integrated with other state-of-the-art techniques such as awake brain mapping of motor and language functions, as well as other higher cortical functions for the safest possible surgery. It also integrates with image guidance using computer navigation tools and techniques.